Europe Liposome Drug Delivery Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product (Liposomal Doxorubicin, Liposomal Paclitaxel, Liposomal Amphotericin B, and Others); Technology (Stealth Liposome Technology, Non-PEGylated Liposome Technology, and DepoFoam Liposome Technology); Application (Fungal Diseases, Pain Management, Cancer Therapy, Viral Vaccines, and Photodynamic Therapy) and Country

Market Introduction

Liposomes are a novel drug delivery system (NDDS); are vesicular structures consisting of bilayers used to deliver drugs or genetic material into a cell. NDDS aims to provide the drug at a rate directed by the body's needs during the period of treatment. Thus, companies in the liposome drug delivery market capitalize on this opportunity to increase their research in nanomaterials such as nanospheres, liposomes, and active antiviral agents. Liposome drug delivery is being leveraged with increased in vivo and in vitro drug activities for routine clinical practices.

Market Overview and Dynamics

The Europe liposome drug delivery market was valued at US$ 1,164.54 million in 2019 and is projected to reach US$ 2,160.12 million by 2027; it is expected to grow at a CAGR of 8.2% during the forecast period. The growing R&D expenditure on drug delivery, growing demand for non-invasive drug delivery devices anddevelopment of new lipid composition for stability and optimization of drugs, are key drivers for liposome drug delivery market. However, the high cost for R&D and COVID-19 pandemic are likely to have a negative impact on market growth.

Key Market Segments

Based on the product, the liposomal doxorubicin segment held the highest share of the Europe liposome drug delivery market in 2019, whereas, liposomal amphotericin B segment is expected to grow at the fastest rate during the forecast period. Based on technology, stealth liposome technology segment held the largest share of the market and is anticipated to grow at the fastest rate during the forecast period. Based on application, cancer therapy segment held the largest share of the Europe liposome drug delivery market in 2019 and is expected to grow at the fastest rate during the forecast period.

Major Sources and Companies Listed

Some of the major primary and secondary sources forEurope Liposome Drug Delivery Market included in the report are novel drug delivery system (NDDS), Celsion Corporation, European and Developing Countries Clinical Trials Partnership (EDCTP), EuropaBio, European Federation of Biotechnology (EFB).

Reasons to buy the report

• Determine prospective investment areas based on a detailed trend analysis of the Europe Liposome Drug Delivery market over the next years.
• Gain an in-depth understanding of the underlying factors driving demand for different Liposome Drug Delivery segments in the top spending countries across the world and identify the opportunities offered by each of them.
• Strengthen your understanding of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
• Identify the major channels that are driving the Europe Liposome Drug Delivery market, providing a clear picture of future opportunities that will be helpful to Analyse, resulting in revenue expansion.
• Channelize resources by focusing on the ongoing programs that are being undertaken by the different countries within the Europe Liposome Drug Delivery market.

EUROPE LIPOSOME DRUG DELIVERY MARKET SEGMENTATION

Europe Liposome Drug Delivery Market – By Product

·         Liposomal Doxorubicin

·         Liposomal Paclitaxel

·         Liposomal Amphotericin B

·         Others

Europe Liposome Drug Delivery Market – By Technology

·         Stealth Liposome Technology

·         Non-PEGylated Liposome Technology

·         DepoFoam Liposome Technology

·         Lysolipid Thermally Sensitive Liposome (LTSL) Technology

Europe Liposome Drug Delivery Market – By Application

·         Fungal Diseases

·         Cancer Therapy

·         Pain Management

·         Viral Vaccines

·         Photodynamic Therapy

  Europe Liposome Drug Delivery Market – By Geography

• UK
• Germany
• France
• Italy
• Spain

1. Takeda Pharmaceutical Company Limited
2. Novartis AG
3. Luye Pharma Group
4. Johnson & Johnson Services, Inc
5. Ipsen Pharma
6. Gilead Sciences, Inc
7. Celsion, Inc
8. Astellas Pharma Inc

• Determine prospective investment areas based on a detailed trend analysis of the Europe Liposome Drug Delivery market over the next years.
• Gain an in-depth understanding of the underlying factors driving demand for different Liposome Drug Delivery segments in the top spending countries across the world and identify the opportunities offered by each of them.
• Strengthen your understanding of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
• Identify the major channels that are driving the Europe Liposome Drug Delivery market, providing a clear picture of future opportunities that will be helpful to Analyse, resulting in revenue expansion.
• Channelize resources by focusing on the ongoing programs that are being undertaken by the different countries within the Europe Liposome Drug Delivery market